![]()
|
|
||||||||
J. Biol. Chem., Vol. 263, Issue 1, 144-149, Jan, 1988
J Mazella, J Chabry, P Kitabgi and JP Vincent
Neurotensin receptors were solubilized from mouse brain using the
zwitterionic detergent 3-[(3-cholamidopropyl)dimethylammonio]-1-
propanesulfonic acid (CHAPS). The binding of 125I-labeled [Tyr3]neurotensin
to the soluble fraction was time-dependent, saturable, and reversible.
Unlabeled neurotensin and its analogues acetylneurotensin (8-13),
neurotensin (9-13), and neurotensin (1-12) competitively antagonized the
binding of 125I-labeled [Tyr3]neurotensin to CHAPS-solubilized extracts
with relative potencies similar to those observed with membrane-bound
receptors. Scatchard analysis of equilibrium binding data indicated that
the soluble extract contained a single class of neurotensin binding sites
with a Kd of 0.36 nM and a Bm of 63 fmol/mg. As already observed with
membrane-bound receptors, the affinity of neurotensin for the soluble
binding activity was decreased by Na+ ions. By contrast, soluble receptors
were no longer sensitive to GTP and the antihistamine drug levocabastine. A
molecular weight of about 100,000 was determined for soluble neurotensin
receptors both under native conditions by gel filtration on Ultrogel AcA 34
and under denaturating conditions by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis after photoaffinity labeling.
Solubilization and characterization of active neurotensin receptors from mouse brain
Centre de Biochimie, Universite de Nice, Faculte des Sciences, France.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
P. J. Lyons, M. B. Callaway, and L. D. Fricker Characterization of Carboxypeptidase A6, an Extracellular Matrix Peptidase J. Biol. Chem., March 14, 2008; 283(11): 7054 - 7063. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Carraway, X. Gui, and D. E. Cochrane Ca2+ Channel Blockers Enhance Neurotensin (NT) Binding and Inhibit NT-Induced Inositol Phosphate Formation in Prostate Cancer PC3 Cells J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 640 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Craig, T. Norberg, D. Griffin, C. Hoeger, M. Akhtar, K. Schmidt, W. Low, J. Dykert, E. Richelson, V. Navarro, et al. Contulakin-G, an O-Glycosylated Invertebrate Neurotensin J. Biol. Chem., May 14, 1999; 274(20): 13752 - 13759. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Dubuc, P. Sarret, C. Labbe-Jullie, J.-M. Botto, E. Honore, E. Bourdel, J. Martinez, J. Costentin, J.-P. Vincent, P. Kitabgi, et al. Identification of the Receptor Subtype Involved in the Analgesic Effect of Neurotensin J. Neurosci., January 1, 1999; 19(1): 503 - 510. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mazella, N. Zsurger, V. Navarro, J. Chabry, M. Kaghad, D. Caput, P. Ferrara, N. Vita, D. Gully, J.-P. Maffrand, et al. The 100-kDa Neurotensin Receptor Is gp95/Sortilin, A Non-G-Protein-coupled Receptor J. Biol. Chem., October 9, 1998; 273(41): 26273 - 26276. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Ward, E. M. Brown, and H. W. Harris Disulfide Bonds in the Extracellular Calcium-Polyvalent Cation-sensing Receptor Correlate with Dimer Formation and Its Response to Divalent Cations in Vitro J. Biol. Chem., June 5, 1998; 273(23): 14476 - 14483. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Schaeffer, M.-C. Laplace, P. Savi, A.-M. Pflieger, D. Gully, and J.-M. Herbert Human Umbilical Vein Endothelial Cells Express High Affinity Neurotensin Receptors Coupled to Intracellular Calcium Release J. Biol. Chem., February 17, 1995; 270(7): 3409 - 3413. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |